ATE112161T1 - Autobiotika sowie deren verwendung bei der in vivo eliminierung körperfremder zellen. - Google Patents

Autobiotika sowie deren verwendung bei der in vivo eliminierung körperfremder zellen.

Info

Publication number
ATE112161T1
ATE112161T1 AT91913184T AT91913184T ATE112161T1 AT E112161 T1 ATE112161 T1 AT E112161T1 AT 91913184 T AT91913184 T AT 91913184T AT 91913184 T AT91913184 T AT 91913184T AT E112161 T1 ATE112161 T1 AT E112161T1
Authority
AT
Austria
Prior art keywords
autobiotics
cells
nongenous
latentiated
vivo elimination
Prior art date
Application number
AT91913184T
Other languages
English (en)
Inventor
Laszlo G Egyud
Original Assignee
Cell Res Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Res Corp filed Critical Cell Res Corp
Application granted granted Critical
Publication of ATE112161T1 publication Critical patent/ATE112161T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT91913184T 1990-07-03 1991-07-01 Autobiotika sowie deren verwendung bei der in vivo eliminierung körperfremder zellen. ATE112161T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/547,983 US5147652A (en) 1990-07-03 1990-07-03 Autobiotics and their use in eliminating nonself cells in vivo

Publications (1)

Publication Number Publication Date
ATE112161T1 true ATE112161T1 (de) 1994-10-15

Family

ID=24186953

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91913184T ATE112161T1 (de) 1990-07-03 1991-07-01 Autobiotika sowie deren verwendung bei der in vivo eliminierung körperfremder zellen.

Country Status (9)

Country Link
US (1) US5147652A (de)
EP (1) EP0537267B1 (de)
JP (1) JPH06501680A (de)
AT (1) ATE112161T1 (de)
AU (1) AU8216691A (de)
CA (1) CA2086513A1 (de)
DE (1) DE69104362T2 (de)
ES (1) ES2065698T3 (de)
WO (1) WO1992000727A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260341A (en) * 1992-07-14 1993-11-09 Agro-K Corporation Inc. Product and process for treating bovine mastitis and bovine metritis
CZ310798A3 (cs) * 1996-03-28 1999-02-17 Trustees Of Boston University Způsob tlumení aktivace tyrosinasy, upravování pigmentace a identifikace látky, látka zesilující fosforylaci tyrosinasy, látka tlumící fosforylaci tyrosinasy, použití činidla tlumícího fosforylaci tyrosinasy, použití peptidu a použití DNA
US6033719A (en) * 1996-04-25 2000-03-07 Medtronic, Inc. Method for covalent attachment of biomolecules to surfaces of medical devices
US6331286B1 (en) 1998-12-21 2001-12-18 Photogen, Inc. Methods for high energy phototherapeutics
US8974363B2 (en) * 1997-12-11 2015-03-10 Provectus Pharmatech, Inc. Topical medicaments and methods for photodynamic treatment of disease
US8557298B2 (en) * 1998-08-06 2013-10-15 Provectus Pharmatech, Inc. Medicaments for chemotherapeutic treatment of disease
US20090117199A1 (en) * 1998-08-06 2009-05-07 Scott Timothy C Method of treatment of cancer
US8470296B2 (en) * 1998-12-21 2013-06-25 Provectus Pharmatech, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
US7384623B1 (en) 1998-12-21 2008-06-10 Provectus Pharmatech, Inc. High energy phototherapeutic agents
US20020001567A1 (en) * 1998-12-21 2002-01-03 Photogen, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
IT1318424B1 (it) * 2000-03-24 2003-08-25 Unihart Corp Composti con attivita' anti-hiv.
US6596755B2 (en) * 2001-07-02 2003-07-22 Dabur Research Foundation Oral formulation of methylglyoxal and its imino acid conjugates for human use
GB0125659D0 (en) * 2001-10-25 2001-12-19 Ssl Int Plc Spermicides
WO2004060346A2 (en) 2002-12-30 2004-07-22 Angiotech International Ag Drug delivery from rapid gelling polymer composition
EP1590440A4 (de) * 2003-02-03 2009-03-18 Palo Alto Inst Of Molecular Me Zellabtötende moleküle und vefahren zu deren verwendung
US20040171175A1 (en) * 2003-02-28 2004-09-02 Swanson Basil I. Process for conjugating biomolecules to hydrophobic membrane-incorporated molecules
WO2016057699A1 (en) 2014-10-07 2016-04-14 Kinsella Timothy J METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER WITH 5-IODO-2-PYRIMIDINONE-2'-DEOXYRIBOSE (IPdR)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4066650A (en) * 1971-02-11 1978-01-03 Egyud Laszlo G Keto-aldehyde-amine addition products and method of making same
US4529561A (en) * 1978-03-24 1985-07-16 The Regents Of The University Of California Method for producing liposomes in selected size range
US4241046A (en) * 1978-11-30 1980-12-23 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4440740A (en) * 1982-04-26 1984-04-03 Merck & Co., Inc. α-Keto aldehydes as enhancing agents of gastro-intestinal drug absorption
DE3218121A1 (de) * 1982-05-14 1983-11-17 Leskovar, Peter, Dr.-Ing., 8000 München Arzneimittel zur tumorbehandlung
US4861588A (en) * 1985-02-05 1989-08-29 New York Blood Center, Inc. Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
CA1270198C (en) * 1984-08-08 1990-06-12 Marcel B Bally ENCAPSULATION OF ANTINEOPLASTIC AGENTS IN LIPOSONES
DE3682257D1 (de) * 1985-11-22 1991-12-05 Takeda Chemical Industries Ltd Liposomzusammensetzung.
JPH0825869B2 (ja) * 1987-02-09 1996-03-13 株式会社ビタミン研究所 抗腫瘍剤包埋リポソ−ム製剤

Also Published As

Publication number Publication date
WO1992000727A1 (en) 1992-01-23
ES2065698T3 (es) 1995-02-16
EP0537267A1 (de) 1993-04-21
DE69104362D1 (de) 1994-11-03
US5147652A (en) 1992-09-15
AU8216691A (en) 1992-02-04
EP0537267B1 (de) 1994-09-28
CA2086513A1 (en) 1992-01-04
DE69104362T2 (de) 1995-05-18
JPH06501680A (ja) 1994-02-24

Similar Documents

Publication Publication Date Title
ATE112161T1 (de) Autobiotika sowie deren verwendung bei der in vivo eliminierung körperfremder zellen.
CA2067541A1 (en) Reduction products of rapamycin
MX9101869A (es) Ciclosporinas, composicion farmaceutica que las contiene y procedimiento para la produccion de las mismas
IT1242710B (it) Apparecchio per la lavorazione del legname.
ATE217883T1 (de) Pentapeptid-amide und -ester, die menslichen krebs hemmen
IT8920505A0 (it) Metodo e disposizione strutturale per la differenziazione tra elementi sonori e sordi del parlato.
ZA914456B (en) Treatment of organ transplantation rejection
ITMI920926A1 (it) Apparecchiatura per la manipolazione di pannelli di carrozzeria di autoveicoli.
ATE114680T1 (de) Lufttrocknende polyurethanharze, deren herstellung und verwendung.
EA200300849A1 (ru) Способы лечения или профилактики кожных заболеваний с помощью cd2-связывающих агентов
FI911620A0 (fi) Kirurgisk sutur och foerfarande foer framstaellning daerav.
DK0513409T3 (da) Anvendelse af et mikrobicidt middel ved fremstilling af betontagsten
DE69111953D1 (de) Herstellung von reduziertem Titan Oxid.
ES2103825T3 (es) Composiciones farmaceuticas que contienen 5-difluorometoxi-2-(3,4-dimetoxi-2-piridil)-metilsulfinil)bencimidazol y un agente anti-helicobacter para el tratamiento de trastornos gastrointestinales.
DE69013871D1 (de) 4-Benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-one und ihre Verwendung als Antikonvulsiva.
NO905291L (no) Fremgangsmaate for behandling av sinkholdige biprodukter og avfallsmaterialer.
DE69114252D1 (de) Reveromycin-a, herstellung und verwendung als antitumormittel sowie als fungizid.
DE3378979D1 (en) 1-acyl-3-pyridylmethylguanidines and their use as antihypertensive agents
DE60045750D1 (de) E5564 zur Verwendung in der Behandlung von Allograft-Abstossung oder Host-versus-Graft-Erkrankungen
DE58906618D1 (de) Strobilurinderivate, ihre Herstellung und Verwendung.
WO2002062204A3 (en) Methods for diagnosing and treating heart disease
DE59006283D1 (de) Alternierende Copolymere, Verfahren zu ihrer Herstellung sowie deren Verwendung.
DE69023331D1 (de) Behandeltes hämoglobin und dessen herstellung.
ATE96039T1 (de) Arzneimittel und ihre verwendung zur behandlung von parasitosen.
IT1237514B (it) Composti ad attivita' antitussiva, processo per la loro preparazione, loro composizioni farmaceutiche.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties